MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Eye, Ocular, Optometry, Ophthalmology, Vision Health Companies
Skye Bioscience, Inc. (NASDAQ: SKYE)*
Organization & Developments: Skye Bioscience
Parents
Skye Bioscience, Inc. (NASDAQ: SKYE)*
Children
*Skye Bioscience Inc is a pre-clinical pharmaceutical company focused on modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma.
2024: Skye Bioscience: Nimacimab Targets Safer Weight Loss, Speculative Buy_seekingalpha.com
2025: Skye Bioscience Partners With Arecor: Potentially Enhanced Nimacimab Dosing
Jumps
Finance & Acquisition: Skye Bioscience
Key People: Skye Bioscience